Related Experiment Video
Updated: Jun 29, 2025
06:17
An Inexpensive Adaptation of a Commercial Microwave Reactor for Solid Phase Peptide Synthesis
Published on: November 22, 2024
390
Autocleaving Bonds for Better Drugs
Jiaqi Guo1, Annabelle Chang1, Bing Xu1
1Department of Chemistry, Brandeis University, 415 South Street, Waltham, MA, 02454, USA.
Chemmedchem
|March 29, 2024
Summary
Medicinal chemists are exploring peptides to control drug release from prodrugs. This novel approach uses peptide-drug conjugates to enhance therapeutic efficacy through controlled hydrolysis for treating bacterial and cancer cells.
Area of Science:
- Medicinal Chemistry
- Molecular Medicine
- Drug Delivery Systems
Background:
- Historically, medicinal chemistry focused on bond formation, with less emphasis on bond cleavage.
- Controlled bond cleavage is crucial for prodrug activation and achieving therapeutic outcomes.
- Current strategies for controlling prodrug cleavage are limited.
Purpose of the Study:
- To introduce a novel strategy for controlling prodrug hydrolysis using peptide conjugates.
- To explore the potential of peptide-drug conjugates for enhanced drug efficacy.
- To highlight a new research direction in molecular medicine.
Main Methods:
- Review of common prodrug strategies.
- Introduction of peptide conjugation as a method to modulate hydrolysis.
- Presentation of representative examples of peptide-conjugated prodrugs.
Main Results:
- Peptides can be leveraged to control the autohydrolysis of peptide-conjugated prodrugs.
- Demonstrated potential for bacterial and cancer cell inhibition.
- Peptide conjugation offers a promising avenue for controlled drug release.
Conclusions:
- Peptide conjugation represents a novel and effective strategy for modulating prodrug hydrolysis.
- This approach holds significant potential for enhancing drug efficacy in treating various diseases.
- Further research in peptide-drug conjugates is warranted for advancing molecular medicine.
Related Concept Videos
01:25Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
206
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
206
00:57C–C Bond Cleavage: Retro-Aldol Reaction
5.7K
The reverse of the aldol addition reaction is called the retro-aldol reaction. Here, the carbon–carbon bond in the aldol product is cleaved under acidic or basic conditions to form two molecules of carbonyl compounds. The mechanism of the reaction consists of three steps.
In the first step, as depicted in Figure 1, the base deprotonates the β-hydroxy ketone at the hydroxyl group to form an alkoxide ion.
In the first step, as depicted in Figure 1, the base deprotonates the β-hydroxy ketone at the hydroxyl group to form an alkoxide ion.
5.7K
00:54Radical Formation: Homolysis
3.6K
A bond is formed between two atoms by sharing two electrons. When this bond is broken by supplying sufficient energy, either two electrons can be taken up by one atom forming ions by the cleavage called heterolysis, or the two electrons are shared by two atoms, with one each creating radicals by the cleavage called homolysis.
3.6K
02:01Alkynes to Carboxylic Acids: Oxidative Cleavage
5.0K
Alkynes undergo oxidative cleavage in the presence of oxidizing reagents like potassium permanganate and ozone. The triple bond — one σ bond and two π bonds — is completely cleaved, and the alkyne is oxidized to carboxylic acids. When warm and basic aqueous potassium permanganate is used as an oxidizing agent, alkynes are first converted to carboxylate salts via an unstable α-diketone intermediate. Further, a mild acid treatment protonates the carboxylate anions...
5.0K
01:15Phase I Reactions: Hydrolytic Reactions
116
Hydrolysis, a cornerstone of phase I biotransformation reactions, uses water to cleave chemical bonds. This process is pivotal in drug metabolism, generating more polar metabolites that can be easily excreted.
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
116